Awasthi, N., Monahan, S., Stefaniak, A., Schwarz, M. A., & Schwarz, R. E. (2017). Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer. Oncotarget.
Citação norma ChicagoAwasthi, Niranjan, Sheena Monahan, Alexis Stefaniak, Margaret A. Schwarz, and Roderich E. Schwarz. "Inhibition of the MEK/ERK Pathway Augments Nab-paclitaxel-based Chemotherapy Effects in Preclinical Models of Pancreatic Cancer." Oncotarget 2017.
Citação norma MLAAwasthi, Niranjan, et al. "Inhibition of the MEK/ERK Pathway Augments Nab-paclitaxel-based Chemotherapy Effects in Preclinical Models of Pancreatic Cancer." Oncotarget 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.